Posterior scleritis after biweekly aflibercept intravitreal injections

PURPOSE: To describe a case of posterior scleritis following anti-vascular endothelial growth factor (VEGF) injection. OBSERVATIONS: A 51-year-old male receiving biweekly anti-VEGF injections for a central retinal vein occlusion complicated with cystoid macular edema presented with new-onset severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hébert, Mélanie, You, Eunice, Gravel, Jean-François, Dirani, Ali, Bourgault, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474326/
https://www.ncbi.nlm.nih.gov/pubmed/36118279
http://dx.doi.org/10.1016/j.ajoc.2022.101696
Descripción
Sumario:PURPOSE: To describe a case of posterior scleritis following anti-vascular endothelial growth factor (VEGF) injection. OBSERVATIONS: A 51-year-old male receiving biweekly anti-VEGF injections for a central retinal vein occlusion complicated with cystoid macular edema presented with new-onset severe pain, photophobia, and tearing. Ophthalmological examination revealed choroidal folds and B-scan ultrasound confirmed significant thickening of the sclera, leading to a diagnosis of posterior scleritis. This resolved under topical and systemic corticosteroids. CONCLUSIONS AND IMPORTANCE: Intravitreal anti-VEGF injections could be associated with non-infectious posterior scleritis. Clinicians should be particularly aware of this possibility in patients receiving frequent injections.

Ejemplares similares